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ABSTRACT 
Background: Patients with type 1 and type 2 diabetes often find it difficult to control their 
blood glucose level on a daily basis because of distance or physical incapacity. With the 
increase in Internet-enabled smartphone use, this problem can be resolved by adopting a 
mobile diabetes monitoring system. Most existing studies have focused on patients’ usability 
perceptions, whereas little attention has been paid to physicians’ intentions to adopt this 
technology. 
  
Objective: The aim of the study was to evaluate the perceptions and user acceptance of 
mobile diabetes monitoring among Japanese physicians. 
Methods: A questionnaire survey of physicians was conducted in Japan. The structured 
questionnaire was prepared in a context of a mobile diabetes monitoring system that controls 
blood glucose, weight, physical activity, diet, insulin and medication, and blood pressure. 
Following a thorough description of mobile diabetes monitoring with a graphical image, 
questions were asked relating to system quality, information quality, service quality, health 
improvement, ubiquitous control, privacy and security concerns, perceived value, subjective 
norms, and intention to use mobile diabetes monitoring. The data were analyzed by partial 
least squares (PLS) path modeling.  
Results: In total, 471 physicians participated from 47 prefectures across Japan, of whom 134 
were specialized in internal and gastrointestinal medicine. Nine hypotheses were tested with 
both the total sample and the specialist subsample; results were similar for both samples in 
terms of statistical significance and the strength of path coefficients. We found that system 
quality, information quality, and service quality significantly affect overall quality. Overall 
quality determines the extent to which physicians perceive the value of mobile health 
monitoring. However, in contrast to our initial predictions, overall quality does not have a 
significant direct effect on the intention to use mobile diabetes monitoring. With regard to net 
benefits, both ubiquitous control and health improvement are significant predictors. Net 
benefits in turn significantly motivate physicians to use mobile health monitoring, and has a 
strong influence on perceived value. Perceived value and subjective norms are predictors of 
intention to use. In our sample, concerns over privacy and security risk have no significant 
effects on intention to use mobile diabetes monitoring. Among the 3 control variables, only 
age significantly affected intention to use mobile diabetes monitoring, whereas experience 
and gender were not significant predictors of intention. 
Conclusions: Physicians consider perceived value and net benefits as the most important 
motivators to use mobile diabetes monitoring. Overall quality assessment does affect their 
intention to use this technology, but only indirectly through perceived value. Net benefits 
seem to be a strong driver in both a direct and indirect manner, implying that physicians may 
perceive health improvement with ubiquitous control as a true utility by enhancing cost-
effective monitoring, and simultaneously recognize it as a way to create value for their 
clinical practices. 
(J Med Internet Res 2012;14(6):e183) 
doi:10.2196/jmir.2159 
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Introduction 
Context and Prior Work 
The increased need for real-time data management and the advances in mobile 
communication technology are developing markets for a new form of remote diabetes data 
management systems [1-3]. Mobile diabetes monitoring (MDM) can provide a more 
personalized and flexible means of control through which physicians can get immediate 
medical data and achieve continuous control over patients’ health, while patients can satisfy 
their desire to receive timely clinical feedback and lower the cost of long-term medical care 
[4,5]. A recent review of 101 commercial mobile apps found that insulin and medication 
recording (62%), data export and communication (60%), diet recording (47%), and weight 
management (43%) are the most prevalent features [1]. The adoption of mobile diabetes 
monitoring has been examined in several situations. A clinical pilot trial in Austria indicated 
that a diabetes management system was well accepted by patients and practical for daily 
usage. A similar application was tested in a randomized and crossover clinical experiment 
with 10 type 1 diabetic patients aged 21 to 62 years in Spain [6]. The patients showed high 
acceptability and interest in the system as recorded in usability and utility questionnaires. 
Martínez-Sarriegui et al [3] tested personal digital assistant (PDA) monitoring with a 
continuous glucose sensor on 5 diabetic patients in Spain. They found that all patients were 
satisfied and would recommend the system. In South Korea, a mobile blood glucometer 
system was tested with 20 elderly patients older than 65 years. Despite complaints related to 
short battery life and difficulties in operating mobile phones, the patients’ satisfaction was 
8.59 of 10 points. 
Significance of the Study 
Our literature review indicates that most published studies focus on the use or clinical 
evaluation of mobile diabetes monitoring from the patients’ perspectives. Empirical research 
on mobile diabetes monitoring adoption from the physicians’ perspective is almost 
nonexistent, thus the present study makes a significant contribution to our existing 
knowledge. Although understanding end users’ (ie, patients) adoption mechanisms is 
important, the adoption of mobile diabetes monitoring needs to be understood from the 
operators’ (ie, physicians) perspectives for two reasons. First, unlike typical commercial 
transactions, patients are not really the customers who choose mobile diabetes monitoring. It 
is the physicians, along with other health professionals, who make the ultimate clinical 
decision to introduce information technology (IT) designed to support highly specialized tasks 
and services [7]. Second, prior research indicates that a close collaboration between 
physicians and the medical device industry is essential for device innovation [8]. In this view, 
physicians provide essential knowledge of technology and medical practice that becomes 
incorporated into new devices. Physicians’ involvement in clinical trials and testing is 
increasingly important, thus the industry needs profound knowledge about the mechanisms of 
their adoption behavior. 
Theoretical Background and Model 
Our theoretical model is based on the updated DeLone and McLean Information System (IS) 
Success Model, which covers different perspectives of evaluating information systems (Figure 
1). DeLone and McLean [9] reviewed the existing definitions of IS success and their 
corresponding measures, and proposed a basic model. Later, this model was revised by 
incorporating 7 major variables connected in structural relationships [10]. System quality is 
defined as the desirable characteristics of an IS, whereas information quality means 
characteristics of the output offered by the IS. Service quality refers to the quality of the 
support that system users receive from the IS department and IT support personnel. Net 
benefits explain the effect an IS has on an individual, group, organization, industry, or society, 
and influence both the usage extent of the IS and the level of resulted satisfaction [11,12]. 
Our research closely follows this model for two reasons. First, prior research suggests that the 
original DeLone and McLean IS Success Model has been one of the most widely cited IS 
models [11,12]. Second, the updated DeLone and McLean IS Success Model is among the 
few options that have incorporated quality and net benefits dimensions that we consider to be 
crucial determinants of mobile diabetes monitoring adoption. 
The updated DeLone and McLean IS Success Model can be considered as a conceptual 
scheme of IS success in a given organization. However, measurements of each variable were 
only loosely suggested. In an attempt to explicate physicians’ adoption of mobile diabetes 
monitoring, we extend the updated DeLone and McLean IS Success Model by introducing 
some new variables. We posit 9 different major hypotheses (H1-H9); our research model is 
shown in Figure 2. 
Overall quality is conceptualized as a second-order hierarchical model in which each first-
order factor is a cause of the construct [13]. That is, overall quality is defined as the ultimate 
result when the IS achieves information, system, and service quality. The reason for this high-
order construct is because although the updated DeLone and McLean IS Success Model 
explains that an information system can be evaluated in terms of information, system, and 
service quality, no overall quality construct was suggested in the model. The extant research 
on service quality perception has always embraced such a hierarchical view [14]. We posit 
that physicians are likely to perform mental calculus by summing up individual quality 
assessment for information, system, and service. Thus, we hypothesize that system quality 
will directly and positively affect overall quality of mobile diabetes monitoring (H1a), 
information quality will directly and positively affect overall quality of mobile diabetes 
monitoring (H1b), and service quality will directly and positively affect overall quality of 
mobile diabetes monitoring (H1c). 
In the updated DeLone and McLean IS Success Model, each quality dimension affects the 
subsequent intention to use the IS. By the same token, our model contemplates that overall 
quality determines the intention to use mobile diabetes monitoring. Actual use is excluded 
from our model, because the current diffusion level of mobile diabetes monitoring is still in its 
infancy. For example, industry reports indicate that although the number of home health 
monitoring devices with embedded cellular connectivity may reach 2.47 million by 2016; 
only 570,000 were in use worldwide as of 2011 [15]. Nonetheless, we argue that physicians 
could judge their intention to use mobile diabetes monitoring without real usage experience, 
because “intention” is an attitude, whereas “use” is a behavior [10]. Therefore, our secondary 
hypothesis is that overall quality will directly and positively affect intention to use mobile 
diabetes monitoring (H2). 
DeLone and McLean [10] argue that satisfaction is an important success measure of system 
adoption because it captures the balance of positive and negative impacts of its use. In our 
model, satisfaction is replaced by perceived value because of the same reason mentioned 
previously―low penetration of mobile diabetes monitoring. Here, we view value as the 
performance improvement in functionality, efficiency, productivity, and practicality because 
of mobile diabetes monitoring adoption as weighed against the associated costs. Because only 
a limited number of physicians may have actually used mobile diabetes monitoring, the level 
of satisfaction is not a realistic measure. Instead, we posit that physicians could perceive 
certain value—perceived trade-off between improved patient care and costs—toward the 
system. However, such value cannot be perceived without a good understanding of overall 
quality. For example, within the general diabetes treatment program, the impact of mobile 
diabetes monitoring on patients cannot be viewed as valuable unless physicians fully evaluate 
the overall performance quality it delivers to the clinical practitioners. Thus, our third 
hypothesis is that overall quality will directly and positively affect perceived value (H3). 
DeLone and McLean [10] suggest that net benefits must be determined by the context and 
objectives of the IS investment by asking the following questions: What qualifies as a 
“benefit”? For whom? And at what level of analysis? In this regard, we conceptualize net 
benefits as a composite effect of two variables: ubiquitous control and health improvement. 
Ubiquitous control is defined as flexible patient care without time and place restriction. 
Ubiquity has been suggested to be the most important utility of mobile device [16], and thus 
the heart of mobile diabetes monitoring benefits. Health improvement in this context 
encompasses the clinical advantages physicians could achieve through the use of mobile 
diabetes monitoring, which have been suggested by several trial experiments [3,6,17]. We 
therefore expect that ubiquitous control will directly and positively affect net benefits (H4a), 
and health improvement will directly and positively affect net benefits (H4b). 
Prior research measures net benefits as improvements in job performance and finds that they 
significantly impact intention to use knowledge-management systems [18,19]. Similar 
findings have been reported in IS literature [12], thus leading us to hypothesize that net 
benefits will directly and positively affect intention to use mobile diabetes monitoring (H5). 
If physicians indeed perceive important benefits derived from mobile diabetes monitoring (ie, 
ubiquitous control and health improvement), they may ultimately see an opportunity to create 
value for their clinical practice. Prior research suggests that such value creation would lead to 
a stronger intention to adopt IS [20]. Thus, the net benefits will directly and positively affect 
perceived value (H6), and perceived value will directly and positively affect intention to use 
mobile diabetes monitoring (H7). 
Next, theory of planned behavior (TPB) states that behavioral intentions are determined by 
three primary dimensions: attitude, subjective norm, and perceived behavioral control. All 
three factors are influenced by a set of cognitive beliefs about the innovation and their 
respective importance. Of special interest to the present study, subjective norm can be defined 
as a “person’s perception that most people who are important to him think he should or should 
not perform the behavior in question” [21]. Prior research based on TPB finds that subjective 
norm has the strongest effect on physicians’ behavioral intentions to share knowledge [22,23]. 
This finding implies that peer influence may play a central role in the adoption of mobile 
diabetes monitoring, leading to the hypothesis that subjective norms will directly and 
positively affect intention to use mobile diabetes monitoring (H8). 
Finally, a general concern for privacy and security risk in mobile commerce may be 
applicable to the adoption of mobile diabetes monitoring. In fact, both industry practitioners 
and scholars have debated potential risks involved in electronic medical records [24-26]. 
Thus, the treatment of personal data and data security can be a negative driver of usage 
intention. Therefore, we posit that privacy and security risk will directly and negatively affect 
intention to use mobile diabetes monitoring (H9). 
Purpose 
The purpose of our empirical survey is to validate the explanatory power of our research 
model, which is a theoretical extension of the updated DeLone and McLean IS Success 
Model. A set of key attitudinal and perceptual factors of mobile diabetes monitoring adoption 
are assessed from the physicians’ point of view. 
 
Figure 1. Updated DeLone and McLean Information System (IS) Success Model. 
 
 
 
 
 
 
Figure 2. Theoretical model of mobile diabetes monitoring adoption among Japanese 
physicians showing various hypothesized (H) relationships. A plus sign or minus sign 
signifies an increase or decrease, respectively, in the dependent variable evoked by an 
increase in the independent variable (ceteris paribus). 
Methods 
Site of the Study 
Japan served as the site for this study for several reasons. First, it has one of the highest 
mobile broadband penetration rates: In 2011, there were 122 million 3G subscribers with 95% 
penetration rate [27]. Second, Japan is the country with the eighth-largest number of diabetes 
patients worldwide in 2010, with approximately 7.3 million adults aged 20 to 79 years [28]. 
According to the World Health Organization (WHO), this number is expected to reach 8.9 
million by 2030 [29]. Thus, an innovative treatment approach for diabetes would draw much 
attention from physicians. Third, with aging of the Japanese population, the health care costs 
associated with chronic diseases are becoming a serious burden in Japan’s social security 
system. To address this issue, there have been various strategic initiatives, of which the first 
two were targeted toward diabetes and depression [29]. Fourth, the direct health care costs of 
diabetes are due to increased costs associated with hospital admissions and outpatient visits, 
as well as the costs of medications. Oishi and colleagues [30] performed a study in 2003, 
examining the time and costs in caring for patients with newly identified type 2 diabetes and 
other lifestyle diseases in Japan. The mean number of monthly doctor visits was similar for 
newly diagnosed patients with diabetes and for patients with hypertension and/or 
hyperlipidemia, but the total time of these visits for patients with diabetes was greater [30]. 
Thus, the adoption of mobile diabetes monitoring could significantly reduce potential costs 
associated with keeping these patients’ diabetes under control. All these reasons ensure the 
ecological validity of the study, and thus justify the use of Japan as the site of the study. 
Definition of Mobile Diabetes Monitoring 
This study defines mobile diabetes monitoring as a system of self-monitoring blood glucose in 
diabetic patients by means of 3G-enabled mobile device. Typically, mobile diabetes 
monitoring enables the following functions: (1) self-monitoring of blood glucose, weight, 
physical activity, diet, insulin and medication, and blood pressure; (2) disease-related data 
export and physician-patient communication; and (3) synchronization with personal health 
record systems at the hospital’s information hub. This technical definition is consistent with 
prior research [1], and leading Japanese medical informatics laboratories and firms (eg, 
University of Tsukuba, Fujitsu) developed a similar system [31,32]. 
Questionnaire 
A questionnaire survey was conducted in Japan. At the beginning of the questionnaire, we 
asked the medical specialty of the respondent and their level of clinical experience (in years). 
We then showed a graphical image of a mobile-based blood glucose self-monitoring system 
developed by the University of Tsukuba [32]. In addition, a detailed description of the system 
purpose, functions, and usage procedures were provided. We asked whether the respondents 
had used mobile diabetes monitoring. If the answer was affirmative, we then asked them to 
rate each item according to their usage experience; otherwise, their assessments were based 
on the description provided in the questionnaire. In the next section, we listed the questions 
related to the model constructs explained in the previous section: system quality, information 
quality, service quality, perceived health improvement, privacy and security concerns, 
perceived value for medical control, subjective norms, ubiquitous control, and intention to use 
mobile diabetes monitoring. Construct measures were adapted from previous research in 
information systems, health care, and consumer behavior [14,16,33-43]. All constructs were 
measured by multiple-item scales with a 7-point Likert scale, except perceived value that was 
measured by a 7-point semantic differential scale. At the end of the questionnaire, some 
demographic questions, such as age, gender, and geographical area (ie, prefecture), along with 
other relevant questions (eg, usage experience and frequency of Internet and mobile device 
use), were included. All constructs’ measures used in the present study are listed in 
Multimedia Appendix 1. 
Participant Recruitment 
The survey participants were recruited by a professional research agency in Japan. The 
agency posted a recruitment notification on its website. As a result, 590 physicians signed up 
to participate in the survey. As an incentive, the respondents were paid 5000 yen 
(approximately US $60) for their participation. The survey website was created and the 
invitation was sent to the participants. Although our sampling was not probabilistic (ie, 
judgment sample), the respondents were drawn from 47 prefectures in Japan, and thus not 
clustered in certain regions of Japan. 
Analytical Approach 
We applied partial least squares (PLS) path modeling as implemented in SmartPLS 2.0 M3 
[44] as means of statistical analysis. PLS has found widespread use in technology adoption 
and information systems literature [45], primarily because of its suitability for exploratory 
studies in early stages of research when the focus lies on saturated, prediction-oriented 
models. We used the factor-weighting scheme as our inner weighting scheme because of its 
robustness [46]. Two of our constructs, overall quality and net benefits, were modeled as 
second-order constructs by using the repeated-indicators approach [45]. We applied 
bootstrapping with 5000 bootstrap samples to obtain inference statistics. 
We performed a PLS analysis with two nested samples. First, we conducted the PLS analysis 
with the total sample. The reason for this is that mobile-based monitoring systems can be 
applied not only to diabetes, but also to epidemiology of other medical fields. Thus, the 
inclusion of other medical experts increases external validity of our proposed model. 
Moreover, the reliability and validity of the measures were assessed with the total sample, 
based on the criteria formulated by Ringle et al [45]. The internal consistency reliability was 
estimated using Cronbach alpha and Jöreskog’s rho. Convergent validity was assessed by 
using the average variance extracted (AVE). We relied on the Fornell-Larcker criterion [47] 
to assess discriminant validity. Second, because diabetes is normally treated by physicians of 
internal medicine and gastrointestinal medicine, we limited the sample only to those 
respondents specialized in these areas. Gastrointestinal symptoms are reportedly common in 
diabetes [48]. This validation with the specialist subsample should reflect more accurate 
perceptual, attitudinal, and behavioral responses from the physicians specialized in this 
specific disease category. 
 
Results 
Sample Characteristics 
During August 2011, 505 physicians responded to the survey. However, there were 34 
responses with exaggerated extremity preferences (all 1s or 7s). They were considered to be 
due to extreme response bias, and were eliminated from the final dataset. Therefore, the total 
usable sample size was 471, with an effective response rate of 79.8%. 
The respondents belonged to diverse specialties (Table 1), including general medicine 
(20.6%), surgery (10.4%), and gastrointestinal medicine (7.9%), among others. The average 
clinical experience of the respondents was 19.3 years. Approximately 87% and 13% of the 
respondents were male and female, respectively, aged 25 to 65 years. A cross-tabulation of 
sex and age group is shown in Table 2. 
 
Table 1. Medical specialties of all respondents (N=471) and those respondents in the 
subspecialties of general internal medicine and gastrointestinal medicine (n=134) to a survey 
in Japan about mobile diabetes monitoring. 
 
 
 
Table 2. Age and sex distribution of respondents to survey in Japan about mobile diabetes 
monitoring. 
In terms of personal use, approximately 42% of the respondents accessed the Internet with 
their mobile device on a daily basis; 9% did so more than 10 times a day. By contrast, 26.9% 
did not access the Internet with mobile device. On average, the respondents used the Internet 
with their mobile device for approximately 7 years. In terms of professional use, 
approximately 30% of the respondents used the Internet for their patient care or other clinical 
practices. With regard to mobile diabetes monitoring, only 0.8% of the respondents actually 
used mobile diabetes monitoring previously. Although 25.9% were aware of its functions but 
did not use mobile diabetes monitoring, 73.2% were not well informed. 
Measurement Validation 
All our constructs exhibit sufficient levels of internal consistency reliability, exceeding the 
recommended threshold of .70 [49]. All AVE values were above the critical value of .50 [47], 
which indicates that all constructs are unidimensional, thus implying convergent validity. In 
Table 3, we report Cronbach alpha, Jöreskog’s rho, and the AVE. 
Table 4 shows the construct correlations as well as the square root of the AVE as the basis for 
assessment of discriminant validity. Comparing the square root of each construct’s AVE with 
its largest absolute correlation shows that the Fornell-Larcker criterion is met. Therefore, 
discriminant validity can also be confirmed. 
 
Table 3. Quality indicators of the constructs, including Cronbach's alpha, Jöreskog’s rho, and 
average variance extracted (AVE). 
 
 
 
 
 
 
 
 
Table 4. Construct correlations and square root of the AVE. 
 
Model Validation with Total Sample 
The results of the PLS analysis on the total sample are shown in Figure 3. The model 
estimates largely confirm our conceptual model. System quality, information quality, and 
service quality all contribute significantly to the overall quality. Remarkably, the indirect 
effect of overall quality on the intention to use mobile diabetes monitoring is positive (indirect 
effect = 0.11) and significant (P < .001). However, the total effect of overall quality on the 
intention to use mobile diabetes monitoring is not significant (total effect = 0.05, P = .21). As 
the indirect effect of overall quality already suggests, both the effect of overall quality on 
perceived value and the effect of perceived value on the intention to use mobile diabetes 
monitoring are significant. Ubiquitous control and health improvement contribute 
significantly to the formation of net benefits. Net benefits, in turn, have significant positive 
effects on the intention to use mobile diabetes monitoring and perceived value. Also, the 
indirect effect (indirect effect = 0.11, P < .001) and the total effect (total effect = 0.38, P 
< .001) of net benefits on the intention to use mobile diabetes monitoring are significant. As 
anticipated, subjective norms have a significant positive effect on the intention to use mobile 
diabetes monitoring. Finally, privacy and security risk does not have a significant effect on 
the intention to use mobile diabetes monitoring. The control variables tested (age, experience, 
and gender of the respondents) did not produce any effect with one exception: the negative 
influence of the age of physicians on intention to use mobile diabetes monitoring. The older 
respondents have a significantly lower intention to use mobile diabetes monitoring than the 
younger respondents, suggesting that the younger the physicians, the more likely they will be 
to adopt and use mobile diabetes monitoring. This effect is likely because of the widely 
documented adverse relationship between age and new technology acceptance. 
Model Validation with Specialist Subsample 
Table 5 lists the results from the PLS analysis of the specialist (internal and gastrointestinal 
medicine) subsample juxtaposed with those from the total sample validation. As far as 
statistical significance is concerned, no discrepancy was found between the two results. 
Except for two paths (ie, overall quality → intention to use mobile diabetes monitoring, and 
privacy and security risk → intention to use mobile diabetes monitoring), all hypothesized 
relationships were supported. Furthermore, the magnitudes of standardized beta coefficients 
were also very similar. 
Hypotheses Testing 
Hypotheses testing results are summarized in the far right column of Table 5. Based on the 
results from both the total sample and the specialist subsample, we could confirm that all but 
two hypotheses are supported by our data. More specifically, system quality, information 
quality, and service quality significantly affect overall quality, providing support for 
hypotheses 1, 2, and 3. Our results also indicate that overall quality determines the extent to 
which physicians perceive the value of mobile health monitoring. However, in contrast to our 
initial predictions, overall quality does not have a significant direct effect on the intention to 
use mobile diabetes monitoring. Thus, hypothesis 2 does not gain support but hypothesis 3 
does. With regard to net benefits, both ubiquitous control and health improvement are 
significant predictors, which ring true for hypotheses 4a and 4b. Net benefits in turn 
significantly motivate physicians to use mobile health monitoring, while exercise strong 
influence on perceived value. Thus, both hypotheses 5 and 6 are supported. Perceived value is 
found to be a strong predictor of intention to use, which provides support for hypothesis 7. In 
the same token, as predicted in hypothesis 8, subjective norms significantly affect intention to 
use. Finally, concerns over privacy and security risk have no significant effects on intention to 
use mobile diabetes monitoring. Thus, hypothesis 9 is not supported. 
 
 
Figure 3. Partial least squares (PLS) analysis results of the theoretical model of mobile 
diabetes monitoring adoption among Japanese physicians. The numbers indicate standardized 
beta coefficients. 
 
 
 
 
 
 
Table 5. Summary of partial least squares (PLS) estimation from the total sample and the 
specialist (internal and gastrointestinal medicine) subsample. 
 
 
Discussion 
Principal Results 
Our proposed model was successfully validated by the total sample and also by the specialist 
subsample. The statistical significance and the strength of standardized coefficients were 
almost identical for all the hypothesized paths. Therefore, for the sake of simplification, our 
principal results are described based on the total sample validation. 
In terms of direct effects, physicians’ intention to use mobile diabetes monitoring is primarily 
influenced by net benefits, perceived value, and subjective norms. Our PLS results indicate 
that the multivariate coefficient of determination (R
2
) value of intention to use mobile diabetes 
monitoring was 0.67 (R
2
 = 0.82 for the specialist subsample), indicating that more than two-
thirds of the variance of this construct can be explained by the model. This value can be 
described as “substantial” according to Chin [50]. 
Net benefits not only have a direct effect on intention, but also an indirect effect through 
perceived value. We thus find evidence for a partial mediation. The hypothesized direct effect 
of overall quality on intention cannot be confirmed, but we find a significant positive indirect 
effect. More specifically, although neither the direct effect nor the total effect of overall 
quality on the intention to use mobile diabetes monitoring is significant, the indirect effect of 
overall quality on the intention to use mobile diabetes monitoring is significant. Given the 
correlation between overall quality and intention to use mobile diabetes monitoring (total R
2
 = 
0.67; specialist subsample R
2
 = 0.70), the influence of overall quality on usage intention 
appears to be fully mediated by perceived value. This means that overall quality contributes to 
forming the intention to use mobile diabetes monitoring only if an increase in overall quality 
is perceived as value added. 
Privacy and security concerns seem to be negligible in terms of their impact on the intention 
to use mobile diabetes monitoring. This is surprising given that there is much documented 
evidence about such concerns in wireless medical devices [51]. One possible explanation is 
that perhaps the respondents of this study might have been more experienced in the use of 
innovative medical devices. Prior research indicates that frequent and experienced users of 
electronic health records were significantly less concerned about privacy and security than 
nonusers [52]. On the other hand, there seems to exist evidence that, compared with general 
business practitioners, many physicians are not particularly technology literate, despite their 
highly demanding educational and specialized training [7]. This lack of computer literacy may 
have made them fail to acknowledge the severity of privacy and security concerns in mobile 
diabetes monitoring. We deem the latter to be a more reasonable and realistic explanation. 
Limitations 
The sample size of physicians specialized in internal medicine or related specialties was 
modest. Future studies should ensure a larger sample to increase the generalizability of the 
findings. Similarly, although the sample consisted of physicians all across Japan (ie, 47 
prefectures), the selection was not probabilistic; thus, it may not accurately reflect the entire 
Japanese medical community. Third, we did not examine how physicians’ personal propensity 
to use new information and communication technology affects the model variables, which 
was far beyond the scope of our study. Because of the preceding reasons, this study should be 
considered as an initial stepping-stone and any generalization of the results should be done 
with caution. 
Conclusions and Practical Implications 
Physicians from a wide range of clinical expertise most valued perceived value as a mediator 
of the effects exercised by both overall quality and net benefits over intention to use mobile 
diabetes monitoring. This fact seems even more significant given the absence of direct effect 
of overall quality on intention to use mobile diabetes monitoring because physicians 
apparently seem to weigh exactly what kind of value they can get out of the system. In health 
care, value is defined as the patient health outcomes achieved relative to the inputs (or cost) 
required [53]. Because net benefits already take into account health outcome (ie, health 
improvement) and device utility (ie, ubiquitous control), our perceived value seems to 
crystallize the importance of the output-input relationship derived from the mobile diabetes 
monitoring. Prior research suggests that the power of quality improvement to drive down 
costs is greater in health care than in any other field [53]. Thus, our results may suggest that 
physicians tend to look into the efficiency and cost-effectiveness of mobile diabetes 
monitoring before forming their usage intention. This implies that the medical device industry 
should be increasingly keen on these aspects in marketing wireless medical monitoring 
systems. 
The impact of subjective norms on intention to use mobile diabetes monitoring was solid, but 
this finding seems somewhat contradictory to the literature. Prior research on telemedicine 
finds no impact of subjective norms on intention, suggesting that physicians may value their 
own assessments over others’ opinions and suggestions [7]. Similarly, the effects of 
subjective norms on intention to use clinical guidelines were reported to be much weaker 
among physicians than among nurses and other clinical professionals [54]. Our interpretation 
is that because many physicians are not particularly computer- or Internet-literate, they may 
rely more on their peers’ or colleagues’ help and suggestions regarding mobile diabetes 
monitoring adoption (ie, medical and IS adoption decisions), whereas they tend to be more 
independent or self-reliant for other knowledge-based practices (ie, purely medical decisions). 
Given the solid effects of subjective norms on intention to use mobile diabetes monitoring, it 
would be wise to organize workshops, seminars, or informative sessions so that knowledge 
and familiarity could be disseminated through word-of-mouth among peers and colleagues. 
Finally, this study would help physicians understand the usefulness of mobile-based health 
care systems. Diabetes is a leading disease in most developed countries and requires constant 
and continuous monitoring. For example, according to the US Department of Health and 
Human Services, diabetes mellitus was listed as the seventh leading cause of death in 2010 
[55]. Mobile technology could encourage diabetic patients to lead healthier lives and facilitate 
earlier discovery of life-threatening symptoms. 
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